phenyl acetate has been researched along with Cognition Disorders in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heo, HJ; Kang, JE; Kang, JY; Kim, DO; Kim, JM; Kwon, BS; Lee, CJ; Lee, U; Park, SH; Park, SK; Seung, TW | 1 |
| de Oliveira, RM; Longhini, R; Mello, JC; Milani, H; Nakamura, CV; Soares, L; Truiti, MT | 1 |
| Goel, RK; Singh, D; Singh, P | 1 |
| Sharma, B; Singh, P | 1 |
| McGilvray, A | 1 |
| Arponen, E; Luoto, P; Någren, K; Oikonen, V; Östberg, A; Rinne, JO; Tenovuo, O; Virta, J | 1 |
| Kumar, A; Mishra, J; Pahwa, D; Prakash, A | 1 |
| Choi, SJ; Heo, HJ; Jeong, HR; Jeong, JH; Jin, DE; Jo, YN; Shin, DH; Song, BG | 1 |
| Akashiba, H; Matsuoka, N; Mitani, Y; Ni, K; Shitaka, Y; Yarimizu, J | 1 |
| Järvenpää, T; Kaasinen, V; Kurki, T; Någren, K; Oikonen, V; Rinne, JO; Roivainen, A; Yu, M | 1 |
| Cohen, LS; Joffe, H; Soares, CN | 1 |
| Brodie, MJ; Girvan, J; Leach, JP; Paul, A | 1 |
| Faught, E; Gilliam, F; Hetherington, H; Ho, S; Kuzniecky, R; Martin, R; Pan, J; Sinclair, K | 1 |
| Faught, E; Gilliam, F; Kuzniecky, R; Martin, R; Meador, K; Sinclair, K; Turrentine, L | 1 |
| Aldenkamp, AP | 1 |
| Burdick, KE; Goldberg, JF | 1 |
| Eichenberger, M | 1 |
| Kashiba, T; Koiwa, M; Okochi, Y; Owada, T; Ueno, K | 1 |
2 review(s) available for phenyl acetate and Cognition Disorders
| Article | Year |
|---|---|
Assessment and treatment of hot flushes and menopausal mood disturbance.
Topics: Acetates; Aging; Amines; Anti-Anxiety Agents; Cognition Disorders; Cyclohexanecarboxylic Acids; Female; Follicle Stimulating Hormone; Gabapentin; gamma-Aminobutyric Acid; Hormone Replacement Therapy; Hot Flashes; Humans; Menopause; Middle Aged; Mood Disorders; Randomized Controlled Trials as Topic; Sleep Wake Disorders | 2003 |
Cognitive side effects of anticonvulsants.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cognition Disorders; Cyclohexanecarboxylic Acids; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Mood Disorders; Topiramate; Triazines; Valproic Acid | 2001 |
4 trial(s) available for phenyl acetate and Cognition Disorders
| Article | Year |
|---|---|
Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease.
Topics: Acetates; Acetylcholinesterase; Aged; Alzheimer Disease; Analysis of Variance; Brain; Carbon Radioisotopes; Cognition Disorders; Female; Hippocampus; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Neuropsychological Tests; Piperidines; Predictive Value of Tests; Reference Values; Tomography, Emission-Computed | 2003 |
Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
Topics: Acetates; Adolescent; Adult; Aged; Amines; Analysis of Variance; Anticonvulsants; Cognition Disorders; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuropsychological Tests | 1997 |
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
Topics: Acetates; Adult; Affect; Amines; Anticonvulsants; Cognition Disorders; Cyclohexanecarboxylic Acids; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Male; Neuropsychological Tests; Psychomotor Performance; Reaction Time; Single-Blind Method; Topiramate; Triazines; Word Association Tests | 1999 |
Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults.
Topics: Acetates; Age Factors; Aged; Amines; Anticonvulsants; Attention; Carbamazepine; Cognition; Cognition Disorders; Cross-Over Studies; Cyclohexanecarboxylic Acids; Double-Blind Method; Female; Gabapentin; gamma-Aminobutyric Acid; Health Status; Humans; Incidence; Male; Middle Aged; Neuropsychological Tests | 2001 |
13 other study(ies) available for phenyl acetate and Cognition Disorders
| Article | Year |
|---|---|
Ethyl acetate fraction from Hibiscus sabdariffa L. attenuates diabetes-associated cognitive impairment in mice.
Topics: Acetates; Acetylcholine; Acetylcholinesterase; Animals; Antioxidants; Behavior, Animal; Biomarkers; Blood Glucose; Brain; Cognition; Cognition Disorders; Diabetes Mellitus, Experimental; GPI-Linked Proteins; Hibiscus; Hypoglycemic Agents; JNK Mitogen-Activated Protein Kinases; Lipids; Male; Mice, Inbred ICR; Neuroprotective Agents; Phosphorylation; Plant Extracts; Poly(ADP-ribose) Polymerases; Solvents; tau Proteins | 2018 |
Trichilia catigua ethyl-acetate fraction protects against cognitive impairments and hippocampal cell death induced by bilateral common carotid occlusion in mice.
Topics: Acetates; Animals; Brain Ischemia; Carotid Artery, Common; Carotid Stenosis; Cell Death; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Male; Maze Learning; Meliaceae; Mice; Plant Extracts | 2015 |
Protective effect on phenytoin-induced cognition deficit in pentylenetetrazol kindled mice: A repertoire of Glycyrrhiza glabra flavonoid antioxidants.
Topics: Acetates; Animals; Anticonvulsants; Antioxidants; Behavior, Animal; Brain; Cognition; Cognition Disorders; Disease Models, Animal; Flavonoids; Glycyrrhiza; Kindling, Neurologic; Lipid Peroxidation; Male; Memory; Mice; Oxidative Stress; Pentylenetetrazole; Phenytoin; Phytotherapy; Plant Extracts; Plant Roots; Plants, Medicinal; Seizures; Solvents; Time Factors | 2016 |
Reversal in Cognition Impairments, Cholinergic Dysfunction, and Cerebral Oxidative Stress Through the Modulation of Ryanodine Receptors (RyRs) and Cysteinyl Leukotriene-1 (CysLT1) Receptors.
Topics: Acetates; Animals; Carotid Artery Diseases; Cerebral Cortex; Cholinergic Agents; Cognition Disorders; Cyclopropanes; Disease Models, Animal; Glutathione; Leukotriene Antagonists; Lipid Peroxidation; Male; Mice; Oxidative Stress; Oxidoreductases; Quinolines; Receptors, Leukotriene; Ruthenium Red; Ryanodine Receptor Calcium Release Channel; Sulfides; Time Factors | 2016 |
Ageing: Restoration project.
Topics: Acetates; Aging; Alzheimer Disease; Animals; Anti-Asthmatic Agents; Cognition Disorders; Cyclopropanes; Estrogens; Female; Hippocampus; Humans; Inflammation Mediators; Leukotrienes; Macaca mulatta; Male; Mice; Neuronal Plasticity; Parkinson Disease; Plasma; Prefrontal Cortex; Quinolines; Rats; Rejuvenation; Sulfides; Synapses | 2016 |
Cholinergic dysfunction after traumatic brain injury: preliminary findings from a PET study.
Topics: Acetates; Acetylcholinesterase; Adult; Brain; Brain Injuries; Brain Mapping; Carbon Radioisotopes; Cognition Disorders; Female; Humans; Male; Middle Aged; Piperidines; Positron-Emission Tomography; Radioligand Assay | 2011 |
Montelukast potentiates the protective effect of rofecoxib against kainic acid-induced cognitive dysfunction in rats.
Topics: Acetates; Acetylcholinesterase; Animals; Antioxidants; Caffeic Acids; Cognition Disorders; Cyclooxygenase 2 Inhibitors; Cyclopropanes; Drug Synergism; Glutathione; Hippocampus; Kainic Acid; Lactones; Leukotriene Antagonists; Lipoxygenase Inhibitors; Maze Learning; Memory; Motor Activity; Neuroprotective Agents; Neurotoxins; Oxidation-Reduction; Oxidative Stress; Quinolines; Rats; Rats, Wistar; Sulfides; Sulfones; Tumor Necrosis Factor-alpha | 2012 |
Antiamnesic effects of ethyl acetate fraction from chestnut (Castanea crenata var. dulcis) inner skin on Aβ(25-35)-induced cognitive deficits in mice.
Topics: Acetates; Alzheimer Disease; Amyloid beta-Peptides; Animals; Catechin; Cell Survival; Chromatography, High Pressure Liquid; Cognition Disorders; Fagaceae; Fluoresceins; Gallic Acid; Hydrogen Peroxide; L-Lactate Dehydrogenase; Learning; Male; Memory; Mice; Mice, Inbred ICR; Neurons; Oxidative Stress; PC12 Cells; Plant Extracts; Rats; Reactive Oxygen Species | 2012 |
Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
Topics: Acetates; Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Antibodies; Chromatography, Liquid; Cognition Disorders; Disease Models, Animal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Hippocampus; Humans; Mass Spectrometry; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Peptide Fragments; Piperidines | 2013 |
Valproate and other anticonvulsants for psychiatric disorders.
Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Anti-Anxiety Agents; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cognition Disorders; Cyclohexanecarboxylic Acids; Dizziness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fructose; Gabapentin; gamma-Aminobutyric Acid; Heart Defects, Congenital; Humans; Lamotrigine; Nausea; Obesity; Stevens-Johnson Syndrome; Topiramate; Triazines; Valproic Acid | 2000 |
Effects of antiepileptic drugs on cognition.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cognition; Cognition Disorders; Cyclohexanecarboxylic Acids; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Piracetam; Tiagabine; Topiramate; Triazines; Triazoles; Vigabatrin | 2001 |
[Clinical experience with centrophenoxine (Lucidril) in internal medicine].
Topics: Acetates; Aged; Central Nervous System Stimulants; Cognition Disorders; Female; Humans; Male; Meclofenoxate; Middle Aged | 1967 |
[Clinical use of Lucidril in conscious disorders].
Topics: Acetates; Adolescent; Adult; Aged; Central Nervous System Stimulants; Child; Cognition Disorders; Electroencephalography; Female; Humans; Male; Meclofenoxate; Middle Aged | 1970 |